John Leaman
Net worth: - $ as of 2024-03-30
Profile
John Harold Leaman worked as the Head of Corporate Development at InfaCare Pharmaceutical Corp.
in 2017.
He was the Chief Financial Officer and Head of Corporate Strategy at Selecta Biosciences, Inc. from 2017 to 2019.
From 2013 to 2016, he served as the Chief Financial Officer at Aevi Genomic Medicine, Inc. and was a Principal at Devon Park Bioventures.
He also worked as an Associate Principal at McKinsey & Co., Inc. Dr. Leaman's education includes an undergraduate degree from Elizabethtown College, a graduate degree from Oriel College, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from Perelman School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Former positions of John Leaman
| Companies | Position | End |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Director of Finance/CFO | 2023-03-09 |
| CARTESIAN THERAPEUTICS, INC. | Director of Finance/CFO | 2019-03-30 |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Corporate Officer/Principal | 2017-08-31 |
| AEVI GENOMIC MEDICINE, INC. | Director of Finance/CFO | 2016-02-08 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Training of John Leaman
| Elizabethtown College | Undergraduate Degree |
| Oriel College | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Perelman School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IPI LEGACY LIQUIDATION CO | Health Technology |
| Private companies | 5 |
|---|---|
InfaCare Pharmaceutical Corp.
InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Devon Park Bioventures
 Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | Finance |
- Stock Market
- Insiders
- John Leaman
